000 01151 a2200289 4500
005 20250515051417.0
264 0 _c20070222
008 200702s 0 0 eng d
022 _a1744-7666
024 7 _a10.1517/14656566.8.1.95
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aBarst, Robyn J
245 0 0 _aSitaxsentan: a selective endothelin-A receptor antagonist, for the treatment of pulmonary arterial hypertension.
_h[electronic resource]
260 _bExpert opinion on pharmacotherapy
_cJan 2007
300 _a95-109 p.
_bdigital
500 _aPublication Type: Comparative Study; Journal Article; Review
650 0 4 _aEndothelin A Receptor Antagonists
650 0 4 _aHumans
650 0 4 _aHypertension, Pulmonary
_xdrug therapy
650 0 4 _aIsoxazoles
_xpharmacology
650 0 4 _aMulticenter Studies as Topic
650 0 4 _aRandomized Controlled Trials as Topic
650 0 4 _aReceptor, Endothelin A
_xphysiology
650 0 4 _aThiophenes
_xpharmacology
773 0 _tExpert opinion on pharmacotherapy
_gvol. 8
_gno. 1
_gp. 95-109
856 4 0 _uhttps://doi.org/10.1517/14656566.8.1.95
_zAvailable from publisher's website
999 _c16732302
_d16732302